Although, the ACE2 (rs4646116) polymorphism did not exhibit a statistically significant effect on COVID-19 risk, the risk of COVID-19 development gradually increased with the presence of each additional risk-associated genotype. The gene discussed is ACE2; the disease is COVID-19.